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Abstract
Objectives: The objective of this randomized controlled trial was to compare alveolar 
ridge preservation using a bone substitute material and covered with a synthetic or 
porcine collagen membrane.
Materials and methods: Thirty-two sockets in the aesthetic maxillary region of 30 
patients were randomized into two groups. Randomization was stratified according 
to bone wall defect. Flapless technique was used, and sockets were grafted with 
bi-phasic calcium phosphate particulate bone substitute and covered by synthetic 
polyethylene glycol (PEG; test group) or porcine-derived collagen membrane (CM; 
control group). No primary closure was attempted. A cone beam computed tomog-
raphy (CBCT) scan was performed immediately after the surgical procedure and re-
peated 22 weeks later. OnDemand3D was used to superimpose scan images and 
assess changes. The mean vertical and horizontal percentage bone loss were calcu-
lated and implants placed after 6 months with or without additional augmentation.
Results: There were no baseline differences between groups or dropouts. The mean 
percentage loss at the labial plate and at the coronal part of the sockets was statisti-
cally significantly lower in the test group compared with controls (−2.86% [SD = 13.48] 
versus 7.42% [SD = 11.95]; 13.45% [SD = 11.97] versus 28.59% [SD = 16.97]). Implants 
were placed after 6 months, and there was no difference in need for further augmen-
tation between PEG (n = 5) or CM (n = 4).
Conclusion: Sites treated with PEG membrane showed less percentage loss in hori-
zontal and vertical measurements in this trial.
K E Y W O R D S
alveolar ridge preservation, bone implant interactions, bone regeneration, dental implant, 
guided bone regeneration, imaging, socket grafting
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1  | INTRODUC TION
Following extraction of a tooth, a series of structural and dimen-
sional changes occur to the alveolar ridge profile as the buccal and 
lingual bone crests migrate apically with more resorption reported 
on the buccal aspect (Araujo & Lindhe, 2005; Cardaropoli, Araujo, & 
Lindhe, 2003). These results are due to the fact that the buccal bone 
has proportionally more bundle bone, which is reliant on an existing 
tooth and its associated function and blood supply whilst the palatal 
aspect has relatively more lamellar bone with a proportionate in-
crease in non-dental blood supply and is thus less influenced by the 
loss or removal of a tooth or teeth (Schropp, Wenzel, Kostopoulos, & 
Karring, 2003; Tan, Wong, Wong, & Lang, 2012).
This reduction in bone can have a significant impact if implant 
retained prosthesis is considered for replacement of the tooth. A 
number of techniques, grouped under the term “alveolar ridge pres-
ervation” (ARP) have been proposed to counteract this resorption 
and maintain alveolar ridge volume to allow for simplified implant 
surgical procedures and optimal aesthetics and function (Darby, 
Chen, & De Poi, 2008; Horvath, Mardas, Mezzomo, Needleman, & 
Donos, 2013; Ten Heggeler, Slot, & Van der Weijden, 2011; Vignoletti 
et al., 2012). Most of these methods make use of various biomate-
rials, with a selection of purported osteo-genetic, osteo-inductive 
or osteo-conductive properties. The materials are generally placed 
in the socket and either left exposed or covered with cell occlusive 
barrier membranes, soft tissue grafts or combinations of these to 
allow undisturbed healing and prevent soft tissue ingress (MacBeth, 
Trullenque-Eriksson, Donos, & Mardas, 2017).
Many studies have compared the various bone substitutes 
used within the socket (MacBeth et al., 2017). However, there is a 
dearth of literature that delves into the effects that the cell occlu-
sive membrane plays in the overall success of these techniques. In 
recent years, synthetic polyethylene glycol (PEG) membrane was 
introduced as a synthetic biodegradable hydrogel that forms in situ 
after the two-component PEG solution is mixed and injected into 
the site. It has been demonstrated in animal and clinical studies that 
PEG membranes work as successfully as animal-derived collagen 
membranes in guided bone regeneration (GBR) simultaneous with 
implant placement, when augmenting bone defects on the buccal 
aspect of implants (Jung, Benic, Scherrer, & Hammerle, 2015; Jung 
et al., 2006; Thoma et al., 2009). Higher rates of delayed soft tis-
sue healing or secondary dehiscence were seen in the PEG mem-
brane group than collagen membrane group in one study (Thoma 
et al., 2009). This, however, had no impact on the eventual bone gain 
after 6 months. Spontaneous epithelialization of the dehisced mem-
brane was reported; this would offer an obvious advantage when 
used in open sockets. Furthermore, less time was required for clin-
ical handling and application of PEG membrane in comparison with 
the collagen membrane.
Although there is evidence to support the application of PEG 
membrane in simultaneous GBR with implant placement, its usage in 
ARP has not been reported previously. Therefore, the primary aim of 
this randomized controlled clinical trial was to compare percentages 
of vertical and horizontal alveolar ridge changes after 6 months of 
healing in extraction sockets grafted with bi-phasic calcium phos-
phate bone substitute and covered with, either porcine-derived 
collagen membrane (CM) or, synthetic polyethylene glycol (PEG) 
membrane. The secondary aim was to assess the number of sockets 
in each group that were suitable for implant placement and whether 
they required additional augmentation at the time of placement.
2  | MATERIAL S AND METHODS
This was a prospective, double-blinded, single-centre randomized 
controlled clinical trial which complies with the CONSORT guide-
lines. Participants, CBCT image assessors and the team performing 
the data analyses were unaware of the membrane placed. The study 
protocol acquired ethical approval from the National Health Service 
(NHS) Research Authority (Registration number 12/LO/1014). The 
trial was conducted under the terms of the Declaration of Helsinki 
with regards to experimentation involving human subjects as well 
as the Global Harmonization Task Force Guidelines for Post Market 
Surveillance Studies and followed the requirements of Good Clinical 
Practice in the form of ISO 14155:2003.
Patients attending the Barts Health NHS Trust Hospital who 
required at least one tooth extraction in the aesthetic maxillary re-
gion (incisor, canine, first premolar) were invited to participate in the 
study. All participants were given a verbal and written outline expla-
nation of the study, and they provided informed written consent. An 
oral examination was subsequently completed, and full medical and 
dental histories were recorded.
Inclusion criteria were as follows: (a) patients had to be 18 years 
or over in age; (b) requiring extraction of a single maxillary ante-
rior tooth in the aesthetic zone due to caries, endodontic failure or 
trauma (including first premolars); (c) the extraction site had to have 
adjacent teeth present.
Exclusion criteria included (a) systemic disease that can interfere 
with dental implant therapy (e.g., uncontrolled diabetes); (b) adjacent 
teeth requiring extraction; (c) greater than one wall of the socket 
missing—assessed at time of extraction; (d) any contraindications for 
oral surgical procedures; (e) history of local irradiation therapy in the 
head-neck region; (f) mucosal diseases (e.g., erosive lichen planus); 
(g) current untreated periodontitis or gingivitis—in particular, prob-
ing depths of >3 mm on one of the teeth immediately adjacent to 
the extraction site; (h) smokers; (i) non-compliant patients; (j) preg-
nant or breastfeeding patients; (k) plaque scores >25%; (l) patients 
involved in current research or who had recently been involved in 
any research prior to recruitment.
The sample size calculation was based on change in bone 
width reported in the study conducted by Fiorellini and colleagues 
(Fiorellini et al., 2005), which demonstrated a mean increase in bone 
width after treatment with 1.50 mg/ml rhbmp-2/ACS of 3.97 mm 
(SD = 2.48) compared to placebo response of 1.79 mm (SD = 1.68). 
This suggested there could be a difference in means of approximately 
2.2 mm. To find a difference of 2.2 mm in bone width between the 
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two groups with a standard deviation of 2.2, with a power of 80% at 
the 5% significance level, 32 sites (16 in each group) were needed.
Participants were randomized into a test or control group. The 
randomization process followed a stratified randomization tech-
nique in order to balance the groups for initial bone defects. It 
included two sets of computer-generated randomization slips cre-
ated for sockets with no bone wall defect (NBD) or bone defect 
(BD). Sockets with no bone wall defect meant that they had intact 
bone walls. Sockets with bone defect meant that the buccal wall 
was not intact and had either a dehiscence or fenestration without 
any soft tissues defect. The dehiscence was defined when buccal 
bone below 3 mm of gingival margin was missing. Fenestration was 
defined as an isolated area with break of continuity of the buccal 
wall but where the marginal buccal bone was intact. Randomization 
F I G U R E  1   Collagen Membrane (CM) in extraction socket with no bone defect (NBD). (a) Alveolus cleaned; (b) Alveolus grafted with bone 
substitute 3mm below the gingival margin; (c) CM tucked into a pouch between the gingiva and the alveolar bone; (d) Cross suture showing a 
slight closure of the gingival edges
(a) (b)
(c) (d)
F I G U R E  2   Polyethylene Glycol (PEG) membrane in extraction socket with no bone defect (NBD). (a) Alveolus cleaned; De-epithelization 
of the sulcular epithelium; (b) Alveolus grafted with bone substitute 3 mm below the gingival margin; (c) Application of PEG membrane below 
the gingival margin; (d) Suture showing a slight closure of the gingival border
(a) (b)
(c) (d)
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was executed by a member of the research team (AG) who oth-
erwise had no contact with the trial's participants. Sequentially 
numbered opaque sealed envelopes were used to conceal allo-
cation. Two sets of envelops were created by the same research 
team member (AG) for sockets with NBD or BD and to guarantee 
they were opaque, sealed and sequentially numbered. They were 
opened in sequential order by the research nurse after tooth ex-
traction, socket degranulation and prior to material placement. The 
study nurse was informed whether the patient had any bone defect 
or not and in turn selected and opened the appropriate envelope to 
reveal which membrane was to be used.
Once informed of the material to be used, the socket was pre-
pared according to the prescribed protocol and the selected ma-
terial placed by one operator only (SS). The clinical techniques are 
illustrated in Figures 1 and 2. Cleaning of the alveolus and a cir-
cumferential de-epithelialization of the sulcular epithelium of the 
extracted tooth with 15c blade was carried out (Figure 1a,b). If no 
bone defect was present, bi-phasic calcium phosphate particulate 
bone substitute (Straumann Bone Ceramic; Straumann AG) soaked in 
saline was placed within the confines of the socket but maintained at 
least 3 mm below the edge of the marginal epithelium (Figure 2a,b). 
It was covered with the randomly selected membrane: either a 
F I G U R E  3   Collagen Membrane (CM) in extraction socket with bone defect (BD). (a) Alveolus cleaned and bone defect confirmed; (b) CM 
tucked into a pouch between the alveolar mucosa and alveolar bone at the point of defect; (c) Alveolus grafted with bone substitute 3 mm 
below the gingival margin and remaining CM wrapped over and into a pouch between the palatal gingiva and the alveolar bone; (d) Cross 
suture showing a slight closure of the gingival edges
(a)
(c)
(b)
(d)
F I G U R E  4   Polyethylene Glycol (PEG) membrane in extraction socket with bone defect (BD). (a) Alveolus cleaned; De-epithelization of the 
sulcular epithelium; (b) Missing bone wall lined with PEG on the inner side of the extraction socket; (c) Alveolus grafted with bone substitute 
3 mm below the gingival margin; (d) Application of PEG membrane below the gingival margin; (e) Suture showing a slight closure of the 
gingival border
(a)
(c) (d) (e)
(b)
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porcine collagen control membrane (Bio-Gide; Geistlich Biomaterials) 
(Figure 1c), or synthetic PEG test membrane (Figure 2c), (Membragel; 
Straumann AG). All surgeries were flapless, and there was neither 
primary closure nor tightening of the edges of the buccal and palatal 
flap (Figures 1d and 2d).
The injectable PEG membrane was prepared according to the 
manufacturer's instructions. A thin layer was applied over the socket 
opening, starting from the buccal side to the palatal following a me-
sial/distal movement whilst ensuring the surface of the membrane 
remained below the level of the marginal epithelium. After the 
membrane set, a tension-free cross suture was placed using a 5–0 
mono-filament polyamide suture (Seralon; Serag-Wiessner) with the 
aim of securing the membrane in place (Figure 2d).
If a defect was present, the randomly selected membrane was 
placed adjacent to the defect, bone substitute was placed and sub-
sequently covered by the same membrane material (Figures 3 and 
4). Patients were prescribed antibiotics (Amoxicillin 250 mg tds); an-
algesics (Ibuprofen 400 mg tds or paracetamol 500 mg qds); and an 
antiseptic mouthrinse (Chlorhexidine 0.2% qds).
A cone beam computed tomography (CBCT) scan was performed 
immediately after the surgical procedure with the patient wearing a 
radiopaque template. This was a tool reference for bone dimensions 
comparison. The CBCT unit used was the Vatech Pax Rev3D. The 
smallest field of view of 5 × 5 cm with the voxel size of 200 mm was 
used with the exposure time of 12 s under 5 mA and 85 kV.
All patients were reviewed at 1-week post-surgery for suture re-
moval and a removable, tooth-supported, provisional prosthesis was 
modified, to ensure it did not make contact with the surgical site. A 
space was maintained to allow for any inflammatory volume increase 
in the soft tissues. There were further reviews at weeks 2, 4, 6, 10 
and 20 for assessing healing and clinical measurements of soft tissue 
closure. At week 22, a second CBCT scan was taken with the same 
radiopaque stent that was used for the first scan and with the same 
parameters as the first CBCT image.
The DICOM (Digital Imaging and Communications in Medicine) 
data were used to compare the dimensional changes with the 
baseline, and follow-up scans were superimposed using the 
OnDemand3D (Ver 1.0.9.3223, CyberMed). Once the two scans 
F I G U R E  5   Sagittal cross-sectional of cone beam computed tomography (CBCT) images from the dental alveolus immediately after socket 
grafting procedure (a) and 6 months later (b)
(a)
(b)
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were uploaded in the software, the “Fusion” tool was used to su-
perimpose them. The software uses a mathematical algorithm 
method that calculates the best fit and automatically superimposes 
the two volumetric images based on voxel-based information. The 
CBCT image at baseline was chosen for the primary image and the 
follow-up image as the secondary image. If the automatic superim-
position obtained was not a perfect fit, the secondary image was 
manually aligned to the primary image using the manual registra-
tion tool. Finally, to ensure that the axis position matched in the 
two volumetric images the function “Reslicing” was used. This tool 
allows the secondary image to be rescaled based on the primary 
image. In this way, measurements can be performed on the same 
slice, at the same position, in both the primary and secondary im-
ages. The images were resliced twice to provide complete super-
imposition (Figure 5). The superimposition between the 2 images 
was presented as coloured images to identify the areas of labial 
bone resorption (Figure 6). A horizontal reference line was traced 
connecting the labial and palatal crest of bone on the immediate 
post-extraction image for standardized measurements. Horizontal 
socket dimensions were measured at distances of 0 (H0), 2 (H2), 4 
(H4), 6 (H6), 8 (H8), 10 (H10) and 12 mm (H12) from the most coro-
nal point of the reference line (Figures 7 and 8). The tooth root axis 
on the immediate post-extraction scan served as the vertical refer-
ence line for the measurements. Vertical measurements using the 
two reference lines were made at: the middle of the socket (V0); 
the labial plate (VLP); the palatal plate (VPP); a distance midway 
from the labial plate to the V0 (VMLP) and; a distance midway from 
palatal plate to V0 (VMPP) (Figures 9 and 10).
In order to minimize the error in measurement, one investigator 
(JM) carried out the superimposition whilst both the observers (JM, 
EG) carried out measurements on the same superimposed images. 
As a result, any discrepancies were limited to the alveolar ridge width 
and height measurements at the predetermined points only. This 
approach eliminated any errors that could have been encountered 
during superimposition of images. Both examiners were trained by 
a Consultant Radiologist and carried out numerous independent 
F I G U R E  6   Magnitude of bone changes seen through the superimposed cone beam computed tomography (CBCT) images of the dental 
alveolus immediately after socket grafting procedure (Blue) and 6 months later (Yellow)
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measurements followed by discussions until they had consistent 
measurements and negligible discrepancies. These discrepancies 
were primarily due to the observer's perception in grey value, and 
agreement was sought along with the Consultant Radiologist if the 
magnitude of the difference was more than twofold.
2.1 | Statistical analysis
Data analysis was computed with SPSS® software (IBM SPSS 
Statistics, v. 24.0. Armonk, NY: IBM Corp.). Mean percentage bone 
loss was calculated for H2, H4, H6, H8, V0, VLP, VMLP, VPP and 
VMPP from CBCT images taken immediately after grafting and after 
22 weeks healing. The mean percentage for the whole sample was 
described, and standard deviations were calculated for each point. 
Two-way ANOVA analysis was performed to compare alveolar ridge 
changes in extraction sockets grafted with bi-phasic calcium phos-
phate and covered with PEG or CM.
The number of sites that needed further GBR at implant place-
ment was counted. Fisher's exact test was used to compare differ-
ences between those treated with CM or PEG.
The 95% confidence interval was considered.
3  | RESULTS
Thirty-two non-adjacent sockets present in 30 patients were treated 
in this study. Twenty patients were male and the mean age was 
40 years (Table 1). There was no statistically significant demographic 
difference between test and control groups (p = .783). All partici-
pants were non-smokers.
Table 2 describes the total distribution of tooth extraction 
sites, the reason for extractions and the differences between test 
and control groups. Test and control groups were comparable 
in relation to extraction sites and reasons for extraction. There 
were 5 fenestration and 3 dehiscence defects allocated to the test 
F I G U R E  7   Horizontal socket dimensions measured at distances of 0 (H0), 2 (H2), 4 (H4), 6 (H6), 8 (H8), 10 (H10) and 12 mm (H12) from 
the most coronal point of the reference line
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group and 3 fenestration, 4 dehiscence and 1 with combined fen-
estration and dehiscence defect that were allocated to the control 
group.
The mean alveolar width measurements and mean percentage 
bone loss for each point is described in Table 3. The greater mean 
percentage bone loss occurred at VLP and H2 and greater variations 
occurred at VLP and VPP.
Differences between test and controls are described in Table 4. 
CM showed a statistically significantly greater percentage bone loss 
at H2 (Mean 28.59 [SD = 16.97]) compared with PEG (Mean 13.45 
[SD = 11.97] [p = .008]); at H4 (Mean 14.84 [SD = 9.91] compared 
with PEG Mean 7.54 [SD = 7.17] [p = .026]); at VMLP (Mean 7.42 
[SD = 11.95] compared to PEG Mean −2.86 [SD = 13.48] [p = .022]). 
There was no statistically significant difference between mem-
branes at H6, H8, VLP, VPP and VMPP. There were no statistically 
significant interaction effects for membrane*presence or absence of 
bone defect.
All sites had an implant placed after 6 months and 9 (28.1%) 
sites required additional augmentation at implant placement or 
at least use of a membrane only (n = 1; Table 5). Six of the sites 
(66.7%) had intact bone walls initially at the time of extraction. 
From these 9 sites, 4 (44.4%) had been treated with CM and there 
was no statistically significant difference between CM or PEG (p-
Value = 1.000). Table 5 describe characteristics of these sites in 
relation to tooth extraction site, type of defect at extraction, pres-
ence of any adverse effect during healing and type of defect at 
implant placement.
4  | DISCUSSION
The results of this randomized controlled trial show that PEG mem-
brane, when used as a socket seal but left exposed over grafted 
extraction socket, preserves more alveolar ridge dimensions after 
F I G U R E  8   Schematic diagram illustrating horizontal measurements. Line “A” represents a horizontal reference line connecting the labial 
and palatal crest of bone on the immediate post-extraction image. Horizontal socket dimensions were measured at distances of 0 (H0), 2 
(H2), 4 (H4), 6 (H6), 8 (H8), 10 (H10) and 12 mm (H12) from line A
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six months when compared to collagen membrane. Both the barrier 
membranes were left exposed in this study, which is in contrast with 
most of the previously published studies on CM, where a flap was 
raised and primary closure either achieved or attempted (Mardas, 
D'Aiuto, Mezzomo, Arzoumanidi, & Donos, 2011).
In the coronal aspects of the socket, PEG showed less horizontal 
and vertical change in comparison to CM. This could be attributed to 
the differences in the application technique of the two membranes. 
For CM, a pouch was created to tuck the membrane between the soft 
tissues and the bone to stabilize the membrane with an additional 
cross suture. In contrast, the PEG was injected and stabilized with a 
cross suture without any need for a pouch. Surprisingly, this difference 
was statistically significant in NBD groups where the intact crestal 
bone should have supported the graft and prevented greater loss. It is 
a possibility that detaching the periosteum from the bone has a det-
rimental effect on bone healing, even though studies seem to have 
contradicted this (Engler-Hamm, Cheung, Yen, Stark, & Griffin, 2011).
Polyethylene glycol membrane stiffens once it polymerises, 
and therefore, it should offer better stability for guided bone re-
generation (GBR). Its use as a barrier in sockets with BD is even 
more interesting for the clinician. Again, in order to line the defect 
inside with a CM, the overlying flap and bone need to be sepa-
rated to insert the membrane as a barrier, before packing the bone 
substitute and folding the remaining length of the membrane over 
the open socket as a seal and secured with a cross suture (Tan-
Chu, Tuminelli, Kurtz, & Tarnow, 2014). Despite careful suturing 
to avoid any tension, some collapse of the coronal aspect was 
noted immediately during the procedure. In comparison, PEG was 
injected along the missing inner socket wall to create a barrier buc-
cally (as all the BD sockets had only buccal wall missing). This did 
not require any manipulation of the buccal soft tissues. Once set, 
bone graft was inserted and a second layer of PEG applied over the 
socket opening and secured with a cross suture. The results con-
firm that within the coronal 4 mm, PEG preserved more alveolar 
F I G U R E  9   Vertical measurements using the two reference lines at the middle of the socket (V0), at the labial plate (VLP), at the palatal 
plate (VPP), at a distance midway from the labial plate to the V0 (VMLP) and at a distance midway from palatal plate to V0 (VMPP)
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ridge width. Another important observation to note here is that 
the CM was applied outside, whereas PEG was applied inside the 
socket wall. In theory, the socket dimension would be reduced by 
the thickness of the layer of PEG when set and yet, a greater socket 
dimension was preserved in the test group.
This study again reinforces the established fact that grafting 
of extraction sockets fails to fully preserve the dimensions of the 
alveolar sockets (MacBeth et al., 2017). However, most of the pre-
vious studies have been conducted on sockets with intact bone or 
at least 3 walls of the socket remaining and greater than 50% of 
the fourth wall remaining after extraction of the tooth (MacBeth 
et al., 2017). Whilst the benefit of grafting such sockets might not 
be clinically significant or beneficial, an attempt at preservation 
of alveolar volume where one socket bone wall is damaged and 
missing, might prevent the need for staged bone augmentation 
procedures for future implant placement. Our results showed that 
71.9% of the treated sockets did not require further GBR at the 
F I G U R E  1 0   Schematic diagram illustrating vertical measurements. Line “B” represents a vertical reference line along the root axis 
denoting the middle of the socket (V0). VLP and VPP represent the Labial and Palatal plates; and VMLP and VMPP represent the point 
midway between the VO to VLP; and VO to VMPP, respectively
TA B L E  1   Description of demographic distribution between test 
(PEG) and control (CM) groups
Test (PEG)
N = 16
Control (CM)
N = 16
Total
N = 32
p-
Value
Gender N (%) N (%) N (%)
Male 11 (68.8) 9 (56.3) 20 (62.5) .716*
Female 5 (31.3) 7 (43.8) 12 (37.5)
Age (years)
Mean 43.7 36.4 40.1 .079**
Median 44.0 37.5 42.0
SD 11.1 11.9 11.9
Min 21.0 19.0 19.0
Max 68.0 52.0 68.0
*p-Values (statistically significant at the level of p < .05) with Fisher's 
exact test. 
**p-Value (statistically significant at the level of p < .05) with 
independent-samples t test for differences in means between groups 
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time of implant placement. The use of PEG or CM over a grafted 
extraction socket was equally likely to decrease the need for fur-
ther augmentation at implant placement.
Most of the previous studies on ARP have included all ex-
traction sites in both maxilla and mandible, thereby subject to a 
wider interpretation of the results and subsequent application to 
clinical situations. In this study, the defects were limited to the 
anterior maxilla extending up to first premolar. Research suggests 
that the majority of alveolar sockets in anterior maxilla, including 
first premolar, have less than 1 mm labial bone thickness (Braut, 
Bornstein, Belser, & Buser, 2011) with a statistically significant 
decrease in thickness from the first premolars to the central inci-
sors. This observation, in combination with well-established the-
ory of bundle bone resorption after extraction of teeth, explains 
why NBD group demonstrated greater percentage bone loss at H2 
and H4 in comparison with BD group, irrespective of the chosen 
barrier membrane.
Most of the previous studies have either used plain film ra-
diographs or CBCT imaging for comparing the changes in bone 
volume. Certainly, plain film before and after grafting would 
offer a very limited perspective of change, only in vertical dimen-
sion. As a result, CBCT images have become a popular method 
Test (PEG)
N = 16
Control (CM)
N = 16
Total
N = 32
p-
Value*
Tooth extraction site N (%) N (%) N (%)
Anterior sites
13 0 (0) 2 (12.5) 2 (6.3) .654
12 3 (18.8) 3 (18.8) 6 (18.8)
11 3 (18.8) 2 (12.5) 5 (15.6)
21 3 (18.8) 4 (25.0) 7 (21.9)
22 2 (12.5) 1 (6.3) 3 (9.4)
23 1 (6.3) 2 (12.5) 3 (9.4)
Premolar sites
14 2 (12.5) 2 (12.5) 4 (12.5)
24 2 (12.5) 0 (0) 2 (6.3)
Reason for extraction
Fractured tooth/Trauma 7 (43.8) 7 (43.8) 14 (43.8) 1.000
Internal resorption/ 0 (0) 1 (6.3) 1 (3.1)
Unsuccessful endodontic 
treatment/
7 (43.8) 6 (37.5) 13 (40.6)
Agenesis with persistent 
deciduous
2 (12.5) 2 (12.5) 4 (12.5)
*p-Values (statistically significant at the level of p < .05) with Fisher's exact test. 
TA B L E  2   Distribution of tooth 
extraction site and reason for extraction 
between test (PEG) and controls (CM)
Measurement point
Alveolar widths 
immediately after 
alveolar ridge 
preservation (mm)
Alveolar widths 
after 22 weeks 
of alveolar ridge 
preservation (mm)
Mean percentage 
bone loss
Mean SD Mean SD Mean SD
Horizontal measurements
H2 7.62 1.25 6.02 1.68 21.02 16.32
H4 8.08 1.34 7.18 1.45 11.19 9.28
H6 8.41 1.68 7.86 1.68 6.61 7.16
H8 8.72 2.03 8.44 2.06 3.26 7.49
Vertical measurements
VLP 9.59 2.88 5.28 4.09 44.03 42.32
VPP 9.97 3.55 8.23 3.65 18.36 24.37
VMLP 10.31 3.04 10.00 2.90 2.27 13.57
VMPP 10.51 3.46 10.12 3.41 2.75 13.90
V0 11.00 3.32 10.87 3.32 0.29 15.08
TA B L E  3   Mean percentage bone loss 
in millimetres for each measurement point 
from immediately after graft procedure 
and after 22 weeks
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of assessing radiographic change in alveolar ridge dimensions 
after bone grafting (Jung et al., 2015; Temmerman et al., 2016). 
However, comparing two CBCT images taken at different time 
points, poses a major challenge when identifying the same slices 
(anatomical points) and therefore measuring changes accurately. 
The methodology used in this study allowed precise superimposi-
tion of the pre- and post-graft CBCT images. The majority of the 
images were automatically aligned by the software used and very 
few required manual alterations to achieve accurate superimpo-
sition to allow for multi-dimensional measurement of ridge width 
and height change in post-grafting CBCT taken after six months. A 
previous study has demonstrated that the standard deviation for 
superimposition using this method was low (0.038 to 0.070 of the 
root mean square in millimetres) and the method of superimposi-
tion using this software was accurate and reproducible (Koerich, 
Burns, Weissheimer, & Claus, 2016). Nevertheless, it remains a 
limitation of this study in particular and CBCT related measure-
ments in general.
Whilst this study demonstrated maintenance of alveolar ridge 
volume in ARP on CBCT images even in sites with missing labial 
bone plate, this does not necessarily always translate into a site 
where (a) an implant can be successfully placed; (b) the quality of 
bone is optimal; (c) successful osseointegration of implant occurs 
and; (d) the regenerated bone is maintained in the long term (De 
Coster, Browaeys, & De Bruyn, 2011). In this study, 28.1% of sites 
required additional augmentation at the time of implant place-
ment. Such sites may have required a block bone graft (staged 
augmentation) if allowed to fully heal for the same time period of 
six months without ARP procedure. Therefore, intervention at ex-
traction may have avoided a need for a more invasive surgery later, 
which carries its own cost implications and patient morbidity. Only 
33.3% of the sites requiring secondary augmentation had missing 
labial bone at the time of extraction. It is plausible that the other 
6 sites with intact labial bone had thin bone phenotype and the 
Measurements
Mean percentage bone loss
β SE
p-
Value
Controls (±SD)
N = 16
Test (±SD)
N = 16
Horizontal measurements
H2 28.59 (16.97) 13.45 (11.97) −15.13 5.26 .008
H4 14.84 (9.91) 7.54 (7.17) −7.29 3.10 .026
H6 6.59 (7.34) 6.64 (7.23) 0.04 2.59 .986
H8 2.62 (7.98) 3.91 (7.17) 1.29 2.72 .637
Vertical measurements
VLP 49.54 (44.38) 38.53 (40.84) −0.78 1.58 .625
VPP 22.78 (27.26) 13.94 (21.04) −8.84 8.57 .311
VMLP 7.42 (11.95) −2.86 (13.48) −12.44 3.81 .003
VMPP 5.51 (15.93) −0.01 (11.37) −5.52 4.93 .272
V0 4.86 (11.91) −4.27 (16.84) −1.11 0.51 .040
TA B L E  4   Differences in mean 
percentage bone loss between test (PEG) 
and controls (CM)
TA B L E  5   Distribution of tooth extraction site, type of defect 
at extraction, reported adverse effect during healing and type 
of defect at implant placement surgery between test (PEG) and 
controls (CM) for participants who required further augmentation 
at implant placement
Test (PEG)
N = 5
Control (CM)
N = 4
Total
N = 9
Tooth extraction 
site
N (%) N (%) N (%)
14 0 (0) 0 (0) 0 (0)
13 0 (0) 1 (25.00) 1 (11.10)
12 2 (40.00) 1 (25.00) 3 (33.30)
11 1 (20.00) 1 (25.00) 2 (22.20)
21 0 (0) 1 (25.00) 1 (11.10)
22 1 (20.00) 0 (0) 1 (11.10)
23 1 (20.00) 0 (0) 1 (11.10)
24 0 (0) 0 (0) 0 (0)
Type of defect at extraction
No defect 3 (60.00) 3 (75.00) 6 (66.70)
Dehiscence 0 (0) 1 (25.00) 1 (11.10)
Fenestration 2 (40.00) 0 (0) 2 (22.20)
Both dehiscence 
and fenestration
0 (0) 0 (0) 0 (0)
Presence of any adverse effect during healing
No 3 (60.00) 4 (100.00) 7 (77.80)
Yes 2 (40.00) 0 (0) 2 (22.20)
Type of defect at implant placement surgery
No defect 0 (0) 1 (25.00) 1 (11.10)
Dehiscence 3 (60.00) 0 (0) 3 (33.30)
Fenestration 2 (40.00) 2 (50.00) 4 (44.40)
Both dehiscence 
and fenestration
0 (0) 1 (25.00) 1 (11.10)
1022  |     SHAHDAD et Al.
inevitable bundle bone resorption accounted for the loss of volume 
thereby necessitating secondary augmentation. Further research 
into the effect of bone phenotype on outcomes of ARP would be 
recommended. Besides, the benefit of ARP is questionable given 
that all the sites would have been amenable to Type II implant 
placement with simultaneous GRB after 6–8 weeks of extraction 
(Buser et al., 2013).
The study included thirty-two non-adjacent sockets in 30 pa-
tients, and the analysis did not consider the potential clustering ef-
fect. Subsequently, the results were confirmed after repeating the 
analysis for 30 sites in 30 patients and randomly excluding one site 
each from the patients who had two grafted sites.
The sample size was calculated based on a previous study re-
porting changes in millimetres (mm) rather than a percentage (%). 
In the present study, the results remained unchanged irrespective 
of whether analysed in mm or %. In the author's opinion, report-
ing % change allows a more comparable interpretation of the results 
and excludes the magnitude of the individual ridge dimensions when 
measuring the change in mm, that is 2 mm loss in a 4 mm and 10 mm 
ridge equates to 50% and 20%, respectively.
Within the limitations of this study, it can be concluded that PEG 
membrane can be successfully used as a barrier over an open socket 
for ARP procedure showing less alteration in horizontal and vertical 
changes in the coronal third in comparison to the CM. The ARP with 
PEG membrane is even more advantageous in defects with missing 
labial bone where an internal barrier can be custom built without the 
need to elevate a flap.
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APPENDIX 1
CONSORT 2010 checkl is t  of  information to include when repor t ing a randomised tr ia l
Note
Section/Topic Item No Checklist item
Reported on page 
No
Title and abstract
1a Identification as a randomised trial in the title Title page
1b Structured summary of trial design, methods, results, and 
conclusions (for specific guidance see CONSORT for abstracts)
Title page
Introduction
Background and objectives 2a Scientific background and explanation of rationale Pages 2-4
2b Specific objectives or hypotheses Page 4
Methods
Trial design 3a Description of trial design (such as parallel, factorial) including 
allocation ratio
Page 4
3b Important changes to methods after trial commencement (such 
as eligibility criteria), with reasons
n/a
Participants 4a Eligibility criteria for participants Pages 4-5
4b Settings and locations where the data were collected Pages 4-5
Interventions 5 The interventions for each group with sufficient details to 
allow replication, including how and when they were actually 
administered
Pages 6-7
Outcomes 6a Completely defined pre-specified primary and secondary 
outcome measures, including how and when they were 
assessed
Pages 7-8
6b Any changes to trial outcomes after the trial commenced, with 
reasons
n/a
Sample size 7a How sample size was determined Page 5
7b When applicable, explanation of any interim analyses and 
stopping guidelines
n/a
Randomisation:
Sequence generation 8a Method used to generate the random allocation sequence Page 5
8b Type of randomisation; details of any restriction (such as 
blocking and block size)
Page 5
Allocation concealment 
mechanism
9 Mechanism used to implement the random allocation sequence 
(such as sequentially numbered containers), describing any 
steps taken to conceal the sequence until interventions were 
assigned
Page 5
Implementation 10 Who generated the random allocation sequence, who enrolled 
participants, and who assigned participants to interventions
Page 6
(Continues)
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Section/Topic Item No Checklist item
Reported on page 
No
Blinding 11a If done, who was blinded after assignment to interventions 
(for example, participants, care providers, those assessing 
outcomes) and how
Page 6
11b If relevant, description of the similarity of interventions Page 6-7
Statistical methods 12a Statistical methods used to compare groups for primary and 
secondary outcomes
Page 8
12b Methods for additional analyses, such as subgroup analyses and 
adjusted analyses
n/a
Results
Participant flow (a diagram is 
strongly recommended)
13a For each group, the numbers of participants who were 
randomly assigned, received intended treatment, and were 
analysed for the primary outcome
Consort diagram
13b For each group, losses and exclusions after randomisation, 
together with reasons
Consort diagram
Recruitment 14a Dates defining the periods of recruitment and follow-up January 2013 – 
March 2016
14b Why the trial ended or was stopped n/a
Baseline data 15 A table showing baseline demographic and clinical 
characteristics for each group
Table 1
Numbers analysed 16 For each group, number of participants (denominator) included 
in each analysis and whether the analysis was by original 
assigned groups
In each table
Outcomes and estimation 17a For each primary and secondary outcome, results for each 
group, and the estimated effect size and its precision (such as 
95% confidence interval)
Pages 8-9
17b For binary outcomes, presentation of both absolute and relative 
effect sizes is recommended
n/a
Ancillary analyses 18 Results of any other analyses performed, including subgroup 
analyses and adjusted analyses, distinguishing pre-specified 
from exploratory
n/a
Harms 19 All important harms or unintended effects in each group (for 
specific guidance see CONSORT for harms)
n/a
Discussion
Limitations 20 Trial limitations, addressing sources of potential bias, 
imprecision, and, if relevant, multiplicity of analyses
Pages 9-13
Generalisability 21 Generalisability (external validity, applicability) of the trial 
findings
Pages 9-13
Interpretation 22 Interpretation consistent with results, balancing benefits and 
harms, and considering other relevant evidence
Pages 9-13
Other information
Registration 23 Registration number and name of trial registry n/a
Protocol 24 Where the full trial protocol can be accessed, if available n/a
Funding 25 Sources of funding and other support (such as supply of drugs), 
role of funders
Straumann Institut, 
Basel, Switzerland
Note: We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for important 
clarifications on all the items. If relevant, we also recommend reading CONSORT extensions for cluster randomised trials, non-inferiority and 
equivalence trials, non-pharmacological treatments, herbal interventions, and pragmatic trials. Additional extensions are forthcoming: for those and 
for up to date references relevant to this checklist, see www.conso rt-state ment.org.
APPENDIX  1   (Continued)
